<p>A: A panel of commonly used urothelial cell lines was screened via traditional RT-PCR for the presence of FOXA1, FOXA2, and FOXA3 transcripts, as well as members of the uroplakin (UPK) family. HepG2 cells, which express each member of the FOXA subfamily, were used as positive controls (data not shown). RT4 cells exhibited robust expression of FOXA1 and as previously reported, UPK family members <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0036669#pone.0036669-Olsburgh1" target="_blank">[20]</a>. FOXA2 expression was detected in T24 cells, but was not correlated with UPK family member expression. FOXA3 was not detected in any tested cell line (data not shown). B:Q-RT-PCR analysis shows FOXA1 expression in the SCaB...
INTRODUCTION: We previously identified common differentially expressed (DE) genes in bladder cancer ...
<p>(A) The quantitative analysis of UHRF1 expression level was carried out in bladder cancer tissues...
Our purpose was to determine the clinical relevance of the detection of circulating tumor cells (CTC...
Approximately 50% of patients with muscle-invasive bladder cancer (MIBC) develop metastatic disease,...
<p>A: Stable knockdown of FOXA1 in human RT4 bladder cancer cells (See <a href="http://www.plosone.o...
We previously found loss of forkhead box A1 (FOXA1) expression to be associated with aggressive urot...
The human uroplakin 1B (UPK1B) gene codes for a structural protein which is a terminal differentiati...
<p>(A) Generation of RT4-Scrambled and RT4-FOXA1 KD cells, as well as T24-pLPCX (empty vector) and T...
Uroplakin 1B (UPKIB) is an integral structural protein interacting with uroplakins 1A, 2 and 3 to fo...
It remains unclear how to implement the recently revealed basal and luminal subtypes of muscle-invas...
To study the effect of gene expression of mouse uroplakin II (UPII) promoter on human bladder cell c...
<p>(<b>A and B</b>) Immunofluorescent double-staining of uroplakin IIIa (top) and SNX31 (middle) in ...
Objectives: Uroplakin (UP) II and UPIII are highly specific immunohistochemical markers for urotheli...
Bladder cancer is one of the most frequent cancers and causes more than 150.000 deaths each year. Du...
目的:研究膀胱移行细胞癌中Uroplakin的表达,探讨它与肿瘤分级的关系.方法:选取96例膀胱移行细胞癌标本,应用免疫组织化学染色方法进行检测.结果:96例膀胱肿瘤标本中,75例Uroplakin表...
INTRODUCTION: We previously identified common differentially expressed (DE) genes in bladder cancer ...
<p>(A) The quantitative analysis of UHRF1 expression level was carried out in bladder cancer tissues...
Our purpose was to determine the clinical relevance of the detection of circulating tumor cells (CTC...
Approximately 50% of patients with muscle-invasive bladder cancer (MIBC) develop metastatic disease,...
<p>A: Stable knockdown of FOXA1 in human RT4 bladder cancer cells (See <a href="http://www.plosone.o...
We previously found loss of forkhead box A1 (FOXA1) expression to be associated with aggressive urot...
The human uroplakin 1B (UPK1B) gene codes for a structural protein which is a terminal differentiati...
<p>(A) Generation of RT4-Scrambled and RT4-FOXA1 KD cells, as well as T24-pLPCX (empty vector) and T...
Uroplakin 1B (UPKIB) is an integral structural protein interacting with uroplakins 1A, 2 and 3 to fo...
It remains unclear how to implement the recently revealed basal and luminal subtypes of muscle-invas...
To study the effect of gene expression of mouse uroplakin II (UPII) promoter on human bladder cell c...
<p>(<b>A and B</b>) Immunofluorescent double-staining of uroplakin IIIa (top) and SNX31 (middle) in ...
Objectives: Uroplakin (UP) II and UPIII are highly specific immunohistochemical markers for urotheli...
Bladder cancer is one of the most frequent cancers and causes more than 150.000 deaths each year. Du...
目的:研究膀胱移行细胞癌中Uroplakin的表达,探讨它与肿瘤分级的关系.方法:选取96例膀胱移行细胞癌标本,应用免疫组织化学染色方法进行检测.结果:96例膀胱肿瘤标本中,75例Uroplakin表...
INTRODUCTION: We previously identified common differentially expressed (DE) genes in bladder cancer ...
<p>(A) The quantitative analysis of UHRF1 expression level was carried out in bladder cancer tissues...
Our purpose was to determine the clinical relevance of the detection of circulating tumor cells (CTC...